A Cohort of Patients Undergoing Percutaneous Coronary Intervention

Recruiting

• Conditions: Acute Coronary Syndrome; Percutaneous Coronary Intervention; Unstable Angina; Myocardial Infarction

• Registration Number: NCT05719545
• Lead Sponsor: Su Guohai

Brief Summary

To investigate the risk factors involved in the occurrence and prognosis of the patients with acute coronary syndrome, patients undergoing percutaneous coronary intervention will be recruited and followed up for at least 2 years.

Detailed Description

Patients with acute coronary syndrome undergoing percutaneous coronary intervention will be recruited and prospectively followed up for the incidence of major adverse cardiovascular events (MACE events), including all-cause mortality, cardiovascular mortality, ischemic stroke. Blood and fecal samples will be collected for further analysis. The basic and clinical information will be collected such as diagnosis, medical history, laboratory test results, therapy methods, prognosis and follow-up information. The risk factors involved in the occurrence and prognosis of acute coronary syndrome will be investigated.

Study Timeline

• Study Start: 2021-12-01
• Status Verified: 2023-01
• Study First Submitted: 2023-01-31
• Study First Submitted QC: 2023-01-31
• Last Update Submitted: 2023-01-31
• Study First Posted: 2023-02-09
• Last Update Posted: 2023-02-09
• Primary Completion: 2026-12-30
• Study Completion: 2026-12-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 10000

Inclusion Criteria

• Diagnosed as acute coronary syndrome and needed to undergo percutaneous coronary intervention.
• >18 years old.

Exclusion Criteria

• With malignant tumors, acute infectious diseases and advanced liver diseases.
• Won't sign an inform consent.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
major adverse cardiovascular events	2-year outcome and long-term outcome	all-cause mortality, cardiovascular mortality, ischemic stroke

Trial Locations

Locations (1)

Jinan Central Hospital; 🇨🇳 Jinan, Shandong, China